2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
- 1 November 2011
- journal article
- practice guideline
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 58 (19), 2020-2045
- https://doi.org/10.1016/j.jacc.2011.08.023
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Revascularization versus Medical Therapy for Renal-Artery StenosisThe New England Journal of Medicine, 2009
- Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and MortalityJAMA, 2008
- Effect on Cessation Counseling of Documenting Smoking Status as a Routine Vital Sign: An ACORN StudyAnnals of Family Medicine, 2008
- Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA TrialJournal of the American College of Cardiology, 2007
- Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trialAmerican Heart Journal, 2006
- Two-Year Outcomes after Conventional or Endovascular Repair of Abdominal Aortic AneurysmsThe New England Journal of Medicine, 2005
- Revascularisation of renal artery stenosis caused by fibromuscular dysplasia: effects on blood pressure during 7-year follow-up are influenced by duration of hypertension and branch artery stenosisJournal of Human Hypertension, 2005
- Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialAmerican Heart Journal, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996